Documente Academic
Documente Profesional
Documente Cultură
posterior communicating or the distal internal carotid arteries very often cause
pain projected to the eye
17
traction on extra-ocular muscles or the iris will evoke pain.
18
Increased intra-ocular pressure causes steady aching type of pain in the region
of the eye and the forehead, as seen in angle closure glaucoma
19
Younger women, menstrual migraine attacks are called catamenial headaches
20
during PET scanning,
reduction in the blood flow in the occipital cortex and spread forward slowly on
both sides,
similar to the concept of spreading cortical depression of Leao.
21
The sensory sensitivity, characteristic of migraine, is proposed to be caused by
a dysfunction of monoaminergic sensory control systems in the brainstem and the
thalamus.
22
Stimulation of the cells in the trigeminal nucleus causes release of
vasoactive neuropeptides,
particularly CGRP (Calcitonin gene-related peptide), at the vascular termination
s of the trigeminal nerve and the within the trigeminal nucleus.
23
CGRP receptor antagonists effective in the treatment of migraine
24
Sensory input modulatory pathways: The key pathway for the pain in an acute atta
ck of migraine is the trigeminovascular input from the meningeal vessels, which
passes through the trigeminal ganglion and synapses on the second order neurons
in the trigeminocervical complex. These neurons project into the quintothalamic
tract and after decussating in the brainstem, synapse on the neurons in the thal
amus
25
Molecular genetic findings of migraine susceptibility:
Four different mis-sense mutations in 1 subunit of P/Q-type, voltage-gated calci
um channel on chromosome 19 are responsible for Familial Hemiplegic Migraine (FH
M) in some families, specifically FHM-1
The gene ATP1A2, which encodes the 2 subunit of NA+/K+ pump is associated with F
HM-2, linked to chromosome 1q23 Mutations of SCN1A gene cause FHM-3. Dopamine D2
receptor gene may also have some affect on the susceptibility of
26
involvement of the neurotransmitter 5-hydroxytryptamine (= 5-HT = Serotonin) in
migraine
27
Dopamine receptor has been shown to be hypersensitive in migraine patients as de
monstrated by induction of vomiting, hypotension and other migraine symptoms by
administering dopamine agonistic drugs in doses that failed to elicit any respon
se in individuals who have never had a migraine headache (non-migraneurs)
28
The efficacy of the triptans is due to their potency at 1B, 1D receptors
29
Migraine with aura :'classical migraine' or 'neurological migraine'
Migraine without aura:'common migraine'.
The ratio of classic: common is usually 1:5.
30
Basilar migraine:
In young women or children with a family history
They first develop visual symptoms
occupy the whole of both the visual fields
associated vertigo, staggering, in coordination of the limbs,
Patients, especially those on oral narcotics, tend to disrupt their migraine tre
atment regime, developing narcotic craving and withdrawal symptoms, which in tur
n can precipitate a migraine attack
45
patients having five or more attacks a month should be considered for preventati
ve management
46
Topiramate = Paraesthesias/Weight loss/Cognitive symptoms/ Glaucoma/nephrolithia
sis
47
Indomethacin-responsive headaches
Orgasmic headaches
Chronic paroxysmal hemicrania
Hypnoeic headache
Brief head pains (jabs, jolts and "ice-pick" headaches)
Prementrual headaches (few cases)
48
Botulinum toxin type A is gaining popularity as a preventative option. This is u
sually an outpatient procedure and is effective in preventing migraine attacks f
or 6 months.
49
Tension-type headache:
most common variety of headache
bilateral with an occipito-nuchal/temporal or frontal/diffuse over the top of th
e cranium
50
Tension-type headache
the head is swollen and might just burst open.
Waves of aching pain are superimposed on this sensation.
If this is interpreted as throbbing or pulsating pain
and
if the pain is slightly more on one side, this could lead to a diagnosis of migr
aine without aura
51
Feature
Migraine
Tension Headache
Persistent throbbing
Yes
No
Photophobia
Yes
No
Phonophobia
Yes
No
Clear, Distinct lateralization of pain
Yes
No
Interference with daily activities
Yes
No
Onset
Within minutes to hours
Gradual
Age of onset
Childhood, Adolescence
Middle age/Adult life
52
Tension-type headache is the only kind of headache where the pain is present thr
oughout the day, day after day, for long periods of time for which the term 'chr
onic tension-type headache' is used
53
tension headaches more common in women.
54
A common and useful clinical approach is to diagnose tension headaches in patien
ts whose headaches are devoid completely of associated symptoms like
The term chronic cluster headache describes attacks occurring for more than 1 ye
ar without remission or with a remission lasting less than 1 month
61
verapamil = 80% reduction in the number of attacks.
Constipation side effect
first-line preventative measure
baseline ECG is taken, and repeated every 6 months.
62
Lithium carbonate is the first choice of treatment of chronic cluster headaches
mechanism of action of unknown
no measurable effect on the cerebral haemodynamics
has a central neurogenic effect influencing the biological clock in the area of
the suprachiasmatic nucleus.
narrow therapeutic window
usually lower than the dose required to treat bipolar disorder
63
Cluster headaches
Methysergide
clonidine
Clomiphene citrate is a synthetic, non-steroidal ovulatory stimulant which alter
s the hypothalamic oestrogen receptors, thus producing an increase in Leuinizing
hormone and follicular stimulating hormone levels with subsequent increase in t
estosterone production
neurostimulation
Deep-brain stimulation in = posterior hypothalamic gray matter
occipital nerve stimulation.
64
Surgical intervention in chronic cluster headache:
Involving sensory trigeminal nerve:
Chemical denervation of the supra-orbital and infra-orbital nerves
Avulsion of the supra-orbital, infra-orbital, supra-trochear nerves
Chemical denervation of the Gasserian ganglion
Retrogasserian glycerol injection
Radiofrequency ganglio-rhizolysis
Trigeminal root section
Gamma knife surgery
Involving the autonomic pathways:
Lesion of the greater superficial petrosal nerve
Lesion of the nervus intermedius
Sphenopalatine ganglion blockade
65
Cluster Variants:
"Trigeminal Autonomic Cephalgia".
Cases of paroxysmal pain behind the eye or nose or in the upper jaw or temple,
associated with the blocking of nostril or lacrimation and
described in the past under the names such as
sphenopalatine, petrosal, vidian or ciliary neuralgia
Chronic paroxysmal hemicrania = unilateral cluster headache
But are of shorter duration (2 to 45 minutes) and usually affect the temporo-or
bital region of one side, accompanied by
conjunctival hyperemia,
rhinorrhoea,
partial Horner's syndrome.
Unlike clusters
paroxysms occur several times in a day,
respond dramatically to indomethacin
66
SUNCT
more frequent, briefer and do not do not usually respond to Indomethacin.
short-lasting
unilateral
neuralgiform attacks with
conjunctival injection and
tearing.
Diagnosis requires at least 20 attacks, lasting for 5-240 seconds,
ipsilateral conjunctival involvement and lacrimation.
If conjuctival component (injection and lacrimation) absent
= SUNA
(Shortlasting
unilateral
neuralgiform attacks with
cranial autonomic symptoms).
Diagnosis: The pain of SUNCT/SUNA is
unilateral
located anywhere in the cranium
may occur as single stabs,
group of stabs or
a longer attack where many stabs occur,
and the pain does not completely resolve between stabs,
thus leading to a "saw tooth" phenomenon.
Diagnosis of SUNCT is easily confused with that of Trigeminal Neuralgia
Minimal presence or
complete absence of autonomic symptoms and
a clear refractory period to triggering indicated a diagnosis of
trigeminal neuralgia.
Secondary SUNCT may be seen with posterior fossa or pituitary lesions.
All with SUNCT or SUNA must be evaluated with pituitary function tests and neuro
imaging:
MRI brain with pituitary views.
Treatment: Therapy of acute attacks in not a useful approach in SUNCT/SUNA since
the attacks are of a very short duration, however,
IV lidocaine arrests the symptoms and are useful in hospitalized patients.
Preventive therapy
anti-convulsants such as lamotrigine 200mg-400mg/day.
Topiramate and
Gabapentin
Surgical approaches
vascular decompression or
destructive trigeminal procedures are not very effective
Nerve stimulations (occipital) useful
Deep brain stimulation useful
Short-term prevention using IV lidocaine may be useful.
67
Hemicrania continua:
moderate, continuous, unilateral with the fluctuations of severe pain,
complete resolution of pain on administration of indomethacin;
exacerbations with autonomic features, including
conjunctival injection, lacrimation, and photophobia on the affected side.
Women are most (female: male 2:1)
between 11 and 58 years.
75
Medication overuse headache/chronic daily headache:
Near-daily headaches
require medication everyday
occurs for nearly 15 of the 30 days in a month
not a single entity, and it encompasses a number of different headache syndromes
could be primary or secondary
episodic primary headache transformed into a chronic headache
"a pattern of greater than or equal to 15 days of primary headache per month for
at least 3 months applies to the use of simple analgesics and caffeine-containi
ng combination analgesics
For patients on narcotics, this is reduced to 10 days a month
Most patients who stop taking the medication will improve significantly
76
Diagnostic Criteria for Chronic Migraine and Medication Overuse
Headache:
Migraine:
*Migraine headache occurring on 15 or more days per month for more than 3 months
in the absence of medication overuse and not attributable to other causes
*Headache which has at least 2 of the 3 qualities:
Unilateral location
Pulsating quality
Moderate to severe intensity
Aggravated with activity
*During the headache, at least one of the following
Nausea and or vomiting
Photophobia and phonophobia
Medication overuse headache:
Headache greater than 15 days per month that has developed or markedly worsened
during the medication overuse
Headache resolves or reverts to its previous pattern with 2 months of discontinu
ing the overused medication
77
Classification of chronic daily headache:
>4 hours per day
Chronic migraine
Chronic tension-type headache
Hemicrania continua
New daily persistent headache
<4 hours a day
Chronic cluster headache
Chronic paroxysmal hemicrania
SUNCT/SUNA
Hypnic headache
Secondary Post traumatic:
Head injury
Iatrogenic
Post-infection
Inflammatory, such as:Giant cell arteritis Sarcoidosis Behet's syndrome
Chronic CNS infection
Medication overuse headache
78
Proposed mechanisms of Chronic headache, Analgesic rebound headache and Medicati
on overuse headache:
The pathophysiology of migraine
Raskin and Appenzeller proposed a continuum model of migraine with aura at one e
nd of the headache spectrum and chronic tension-type headache at the other and b
etween these two extremes are the different clinical phenotypes of primary heada
ches observed in clinical practice.
migraine becomes more chronic, the threshold for the next migraine is lowered an
d that analgesics and ergotamine expedited this change in threshold.
gastrointestinal and neurovascular symptoms as the chronocity set in,
greater association of myogenic and psychological symptoms.
A 'convergence hypothesis'
primary headaches, at least in the migraine population, evolved from a single pa
thophysiological mechanism.
Treatment:
The first step is to diagnose and rule out any underlying condition. For patient
s with primary headaches, the diagnosis of the headache type will guide the trea
tment choice.
Preventive treatments
such as tricyclic antidepressants (amitriptyline or nortriptyline) at doses up t
o 1mg/klg are very useful in patients with chronic headache arising from migrain
e or tension type headaches. They are started at low doses and given in twice-da
ily doses.
Anticonvulsants like topiramate, valproate and gabapentin are also useful in mig
raineurs. Flunarizine has been found to be especially useful.
Medically intractable chronic daily headache:
Most promising approach thus far seems to be occipital nerve stimulation.
Medication overuse headache:
Outpatients: First step is to reduce and eliminate the analgesic responsible. Th
is can be done by reducing the dose of the analgesic by 10% every 1- 2 weeks.
A small dose of an NSAID such as Naproxen (500mg BiD) will help relieve residual
pain.
NSAID overuse is not usually a problem when taken 1 or 2 times in a day.
Preventive medications usually don't work in the presence of analgesics and usua
lly take about 2 weeks for their action to set in.
Inpatients:
if the patient has been using a narcotic agent. Such patients have typically fai
lure efforts at outpatient withdrawal or have developed a significant addiction.
With medical conditions such as Diabetes Mellitus also require admission, since
the medical condition could complicate on withdrawal of the analgesic.
Anti-emetics and fluids are administered as required.
Clonidine is used for opioid withdrawal.
For acute intolerable pain in the waking hours, IV aspirin (1gram) is used.
IM chlorpromazine can be helpful at nighttime.
After 3 to 5 days, diethylergotamine may be introduced IV, for about 5 days, at
a TiD dose.
This is then stopped and a preventive agent may be introduced.
79
Posttraumatic Headache:
Severe, chronic, continuous or intermittent headaches lasting days or weeks
separable in every way from the headache that immediately follows head injury (s
uch as pain of a scalp laceration or cerebral contusion with blood).
In cases of a chronic subdural haematoma, the pain is deep-seated, dull steady,
81
Headache secondary to meningitis:
Meningitis typically presents with severe headache, with neck stiffness and feve
r. A lumbar puncture is diagnostic of meningitis. Patients also complain of phot
ophobia. There is an undeniable accentuation of pain on eye movement. Meningitis
can be easily mistaken for migraine in that the cardinal symptoms of pounding h
eadache, photophobia, nausea, and vomiting are frequently present. Treatment fol
lows the medications for the underlying meningitis. Gluocorticoids may help in d
ecreasing the intracranial pressure and thus the headache.
82
Headache secondary to a brain tumour:
Approximately 30% of patients with a brain tumour present with headache as the m
ain symptom. The headache is usually non-descript, usually intermittent, dull, d
eep aching of moderate intensity, which usually increases due to exertion or cha
nge in position, and may be associated with vomiting. Symptoms are thus similar
to that of migraine headaches.
Vomiting that precedes the appearance of headache by weeks is highly characteris
tic of posterior fossa brain tumors.
Head pain appearing abruptly after bending, lifting, or coughing can be due to a
posterior fossa mass, a Chiari malformation, or low CSF volume.
The diagnosis is made by neuroimaging such as CT scan and/or MRI with/ without c
ontrast.
stereotactic biopsy may be indicated
83
Headache secondary to temporal arteritis:
Temporal arteritis or giant cell arteritis is an inflammatory disorder, which fr
equently involves the extracranial circulation of the carotid artery.
Common disorder of elderly
average age of onset is 70 years,
women more than half of cases.
half of patients with untreated temporal arteritis develop blindness
due to involvement of the ophthalmic artery
The ischaemic optic neuropathy induced by giant cell arteritis is a major cause
of rapidly developing blindness in patients >60 years of age.
Presenting symptoms include:
Headache
Polymyalgia rheumatica
Jaw claudication
Fever
Weight loss
may be unilateral or bilateral
in most cases is located temporally but may present in any other part of the cra
nium.
Pain usually increases over hours, gradually before peaking.
dull and boring type of pain, with superimposed stabbings.
Most patients can recognize that the origin of their head pain is superficial, e
xternal to the skull, rather
than originating deep within the cranium.
Scalp tenderness may be marked,
so much so that combing the hair or resting the head on a pillow may be too pain
ful.
may be worse at night, and aggravated by exposure to cold.
Patients may also present with red streaking of the skin overlying the temporal
arteries, and tenderness over the temporal or less commonly the occipital arteri
es.
In its most basic level, migraine is headache with associated features, while te
nsion headache is featureless.
Tension-type headache is the most common variety of headache.
Tension-type headache is the only kind of headache where the pain is present thr
oughout the day, day after day, for long periods of time for which the term 'chr
onic tension-type headache' is used.
Cluster headache
The pain is deep, usually retro-orbital, often excruciating in intensity, non-fl
uctuating and explosive in quality.
A core feature of cluster headache is periodicity.
cluster headache may be preceded by prodromal as a vague discomfort or poorly de
scribable feeling in the region of one eye, temple, forehead, or neck.
Fatigue, euphoria, depression or mood changes, apathy, irritability, and photoph
obia and phonophobia may be experienced.
Treatment of a cluster headache includes administration of oxygen, sumatriptan a
nd other agents such as parenteral ketorolac, chlorpromazine, lidocaine, etc.
Preventative measures include the use of methyl prednisone for short term, verap
amil, methysergide, etc for a longer-term prophylaxis.
When the medical therapies fail, neurostimulation strategies may be employed.
A small percentage of patients with chronic cluster headaches who do not respond
to pharmacological therapy may benefit from surgical intervention.
This is considered only in those patients who are suffering from strictly unilat
eral headaches.
Apart from symptomatic management, the most important part of treatment of secon
dary headache involves the dealing with the underlying condition that is actuall
y causing the headache.
==
Craniofacial Pains
Acute Zoster and Post-herpetic pain:
Neuralgia affect cranial as well as peripheral nerves.
In the Cranial nerve regions, two syndromes :
Herpes zoster auricularis
Herpes zoster ophthalmicus
Both may be exceedingly painful, especially in the acute condition.
periodontal abscess.
The pain of dental nerve origin is most severe at night,
slightly pulsating, associated with local tenderness at the root of the tooth
in response to heat, cold, or pressure.
eradicated by infiltrating the base of the tooth with lidocaine.
Trigeminal neuritis may be iatrogenic, following dental extractions or
oral surgery is another vexing problem.
There may be sensory loss in the tongue
or lower lip and weakness of the masseter or pterygoid muscle.
Treatment:
isolation of the affected region by local anesthetic blocks
Curetted the bone, and administered antibiotics
Following the above the pain resolved.
The removed bone fragments showed vascular and inflammatory changes and infectio
n with oral bacterial flora.
Facial Pain of Uncertain Origin ("Atypical" Facial Pain)
most often young women,
who describe the pain as constant and unbearably severe, deep in the face, or at
the angle of cheek and nose and unresponsive to all varieties of analgesic medi
cation.
depression of varying severity is found in nearly half. Many such patients, with
or without depression, respond to tricyclic antidepressants and monoamine oxida
se inhibitors.
requires close observation of the patient,
looking for lesions such as nasopharyngeal carcinoma
The pain should be managed by the conservative and not by destructive surgery.
Antidepressants
==
Trigeminal Neuralgia
prosopalgia,
Suicide disease,
Fothergill disease
tic douloureux
More than one nerve branch can be affected by the disorder.
In most cases (unilateral),/right side.
Rarely,(bilateral).
60 to 70 years of age.
Females are affected up to twice as often as males.
Patients who present with the disease when aged 20-40 years are more likely to s
uffer from a demyelinating lesion in the pons secondary to multiple sclerosis
Another risk factor for this syndrome is hypertension
Types:
Trigeminal neuralgia is mainly classified into 2 main types
Type 1:Episodic
Causes extreme, sporadic, sudden burning or shock-like facial pain that lasts an
ywhere from a few seconds to as long as two minutes per episode.
These attacks can occur in quick succession, in volleys lasting as long as two h
ours.
Type 2:Constant
Characterized by constant aching, burning, stabbing pain of somewhat lower inten
sity than Type 1.
Pains from the nose or paranasal sinuses - the pains from sinusitis are usually
preceded by cold, are constant and usually associated with a fever. They become
throbbing when the secretions block the sinus outlets. Clinical examination and
X-ray of the paranasal sinuses (PNS view) or CT scan of paranasal sinuses is hel
pful.
Ocular or orbital pains
mimic pains of ophthalmic or first division neuralgia. T
he most common cause is a glaucoma which produces intense, throbbing pain in and
around the eye. A good clinical examination and tonometry is helpful.
Diabetic cranial neuropathies can involve branches of trigeminal nerve and produ
ce facial pains. Clinical examination and blood sugar level estimations are help
ful.
Management:
carbamazepine(600-1200mg/d),
oxcarbazepine,
gabapentin(300-900mg/d),
pregabalin 150-300mg/d),
clonazepam (2-6mg/day),
phenytoin(300-400mg/d) and
valproic acid (800-1200mg/d).
Carbamazepine is effective in 70-80% of the patients, but half become tolerant o
ver a period of several years.
Tricyclic antidepressants such as amitriptyline or nortriptyline can be used to
treat pain.
Common analgesics and opioids are not usually helpful
if medication fails to relieve pain or produces intolerable side effects such as
cognitive disturbances, memory loss, excess fatigue, bone marrow suppression, o
r allergy, then surgical treatment may be indicated.
Surgery
presence of multiple sclerosis,
upper/ophthalmic branch is involved
facial numbness is expected after many of these procedures
surgical risks
hearing loss, balance problems, leaking of the cerebrospinal fluid (the fluid th
at bathes the brain and spinal cord), infection, anesthesia dolorosa (a combinat
ion of surface numbness and deep burning pain), and stroke, although the latter
is rare.
A rhizotomy nerve fibers are damaged to block pain.
causes some degree of sensory loss and facial numbness.
Balloon compression works by injuring the insulation on nerves that are involved
with the sensation of light touch on the face.
The procedure is performed in an operating room under general anesthesia.
A tube called a cannula is inserted through the cheek and guided to where one br
anch of the trigeminal nerve passes through the base of the skull. A soft cathet
er with a balloon tip is threaded through the cannula and the balloon is inflate
d to squeeze part of the nerve against the hard edge of the brain covering (the
dura) and the skull. After about a minute the balloon is deflated and removed, a
long with the catheter and cannula. Balloon compression is generally an outpatie
nt procedure, although sometimes the patient may be kept in the hospital overnig
ht. Pain relief usually lasts one to two years.
Glycerol injection is also generally an outpatient procedure in which the indivi
dual is sedated with intravenous medication. A thin needle is passed through the
cheek, next to the mouth, and guided through the opening in the base of the sku
ll where the third division of the trigeminal nerve (mandibular) exits. The need
le is moved into the pocket of spinal fluid (cistern) that surrounds the trigemi
nal nerve center (or ganglion, the central part of the nerve from which the nerv
e impulses are transmitted to the brain). The procedure is performed with the pe
rson sitting up, since glycerol is heavier than spinal fluid and will then remai
n in the spinal fluid around the ganglion. The glycerol injection bathes the gan
glion and damages the insulation of trigeminal nerve fibers. This form of rhizot
omy is likely to result in recurrence of pain within a year to two years. Howeve
r, the procedure can be repeated multiple times.
Radiofrequency thermal lesioning (also known as "RF Ablation" or "RF Lesion") is
most often performed on an outpatient basis. The individual is anesthetized and
a hollow needle is passed through the cheek through the same opening at the bas
e of the skull where the balloon compression and glycerol injections are perform
ed. The individual is briefly awakened and a small electrical current is passed
through the needle, causing tingling in the area of the nerve where the needle t
ips rests. When the needle is positioned so that the tingling occurs in the area
of TN pain, the person is then sedated and the nerve area is gradually heated w
ith an electrode, injuring the nerve fibers. The electrode and needle are then r
emoved and the person is awakened. The procedure can be repeated until the desir
ed amount of sensory loss is obtained; usually a blunting of sharp sensation, wi
th preservation of touch. Approximately half of the people have symptoms that re
occur three to four years following RF lesioning. Production of more numbness ca
n extend the pain relief even longer, but the risks of anesthesia dolorosa also
increase.
Stereotactic radiosurgery (Gamma Knife, Cyber Knife) uses computer imaging to di
rect highly focused beams of radiation at the site where the trigeminal nerve ex
its the brain stem. This causes the slow formation of a lesion on the nerve that
disrupts the transmission of sensory signals to the brain. People usually leave
the hospital the same day or the next day following treatment but won't typical
ly experience relief from pain for several weeks (or sometimes several months) f
ollowing the procedure. The International Radio Surgery Association reports that
between 50 and 78 percent of people with TN who are treated with Gamma Knife ra
diosurgery experience "excellent" pain relief within a few weeks following the p
rocedure. For individuals who were treated successfully, almost half have recurr
ence of pain within three years.
Micro-vascular decompression (MVD) is the most invasive of all surgeries for TN,
but also offers the lowest probability that pain will return. About half of ind
ividuals undergoing MVD for TN will experience recurrent pain within 12 to 15 ye
ars. This inpatient procedure, which is performed under general anesthesia, requ
ires that a small opening be made through the mastoid bone behind the ear. While
viewing the trigeminal nerve through a microscope or endoscope, the surgeon mov
es away the vessel (usually an artery) that is compressing the nerve and places
a soft cushion between the nerve and the vessel. Unlike rhizotomies, the goal is
not to produce numbness in the face after this surgery. Individuals generally r
ecuperate for several days in the hospital following the procedure, and will gen
erally need to recover for several weeks after the procedure.
A neurectomy (also called partial nerve section), which involves cutting part of
the nerve, may be performed near the entrance point of the nerve at the brain s
tem during an attempted microvascular decompression if no vessel is found to be
pressing on the trigeminal nerve. Neurectomies also may be performed by cutting
superficial branches of the trigeminal nerve in the face. When done during micro
-vascular decompression, a neurectomy will cause more long-lasting numbness in t
he area of the face that is supplied by the nerve or nerve branch that is cut. H
owever, when the operation is performed in the face, the nerve may grow back and
in time sensation may return. With neurectomy, there is risk of creating anesth
esia dolorosa.
Surgical treatment for TN2 is usually more problematic than for TN1, particularl
y where vascular compression is not detected in brain imaging prior to a propose
d procedure. Many neurosurgeons advise against the use of MVD or rhizotomy in in
dividuals for whom TN2 symptoms predominate over TN1, unless vascular compressio
n has been confirmed. MVD for TN2 is also less successful than for TN1.
Complementary approaches
Some individuals manage trigeminal neuralgia using complementary techniques, usu
ally in combination with drug treatment. These therapies offer varying degrees o
f success. Some people find that low-impact exercise, yoga, creative visualizati
on, aroma therapy, or meditation may be useful in promoting well-being. Other op
tions include acupuncture, upper cervical chiropractic, biofeedback, vitamin the
rapy, and nutritional therapy. Some people report modest pain relief after injec
tions of botulinum toxin to block activity of sensory nerves.
Chronic pain from TN is frequently very isolating and depressing for the individ
ual. Conversely, depression and sleep disturbance may render individuals more vu
lnerable to pain and suffering. Some individuals benefit from supportive counsel
ing or therapy by a psychiatrist or psychologist. However, there is no evidence
that TN is psychogenic in origin or caused by depression, and persons with TN re
quire effective medical or surgical treatment for their pain.
==
Glossopharyngeal Neuralgia
"Glossopharyngeal neuralgia is a rare condition characterized by paroxysms of pa
in in the sensory division of the ninth cranial nerve".
-Waldman's textbook of pain management 2nd Edition.
Glossopharyngeal neuralgia is much less common compared to Trigeminal neuralgia,
but resembles it in many respects. The description of this entity dates back to
the 1910-1920s. In 1910, Weisenburg first described the pain in the distributio
n of the glossopharyngeal nerve in a patient with a cerebellopontine angle tumou
r. In 1921, Harris reported the first case and coined the term "glossopharyngeal
neuralgia"
Clinical presentation:
Population studies have shown that glossopharyngeal neuralgia is 100 times less
common when compared to trigeminal neuralgia. It is more commonly seen in patien
ts older than 50 years. It occurs in episodes, with the pain in each episode las
ting from a few seconds to minutes. Paroxysms of pain are often triggered by act
ivities such as chewing, coughing, laughing, talking or yawning.
Pain is described as shooting/stabbing/needle-like.
It occurs in paroxysms.
Pain is localized in the ear or radiate from the throat to the year, thereby imp
licating the auricular branch of the vagus nerve. Investigators have noted the s
pread of pain beyond the distribution of the glossopharyngeal nerve to areas inn
ervated by the vagus (as mentioned above) and the upper cervical segments. This
is referred to as overflow pain.
Overflow pain has been postulated as occurring due to spillover of the intense i
mpulses from the glossopharyngeal nerve through the tractus solitarius of the me
dulla to the vagus nerve.
Fibres of the glossopharyngeal nerve may also join the decending portion of the
trigeminal nerve, thereby contributing to this phenomenon.
Involvement of the vagus nerve concomitantly has been noted for a long time, wit
h glossopharyngeal neuralgia being the main craniofacial neuralgia that may be a
ccompanied by bradycardia and even syncope, presumably because of the triggering
of the cardio-inhibitory reflexes by the afferent vagal pain impulses.
There is no demonstrable sensory or motor deficit.
In very rare cases, carcinoma or epithelioma of the otopharyngeal-infracranial r
egion or peritonsillar abscess may give rise to a pain that is clinically indist
inguishable from glossopharyngeal neuralgia.
Diagnosis:
As with other headaches, a targeted history and physical examination contributes
significantly in arriving at the diagnosis. Most cases are idiopathic.
Most cases of glossopharyngeal neuralgia are idiopathic; however, care must be t
aken to exclude tumors of the head and neck, especially those that occur at the
cerebellopontine angle that may be the cause of the patient's symptoms
Although the condition is exceedingly rare, a careful cardiac examination is ind
icated to rule out glossopharyngeal neuralgia with associated syncope.
Idiopathic glossopharyngeal neuralgia has four major characteristics that includ
e:
A history of shooting, stabbing, shock-like pain in the neck, throat, or ear tha
t occurs in paroxysms and is triggered by talking, chewing, drinking or coughing
;
The neurologic examination results are normal, and the ear, pharynx, hypopharynx
, piriform sinuses, and larynx are free from objective disease
The patient is relatively pain free between attacks and can carry out normal act
ivities
The pain is markedly improved or relieved by blockade of the glossopharyngeal ne
rve with local anesthetic.12 Dull, aching, poorly localized pain that persists b
etween paroxysms of tic-like pain is strongly suggestive of a space-occupying le
sion and requires a thorough evaluation
Treatment:
In most patients, the pain of glossopharyngeal neuralgia can be controlled. In t
he acute, uncontrolled attack of glossopha- ryngeal neuralgia, hospitalization i
s indicated to facilitate the relief of pain and to monitor for side effects fro
m the treatments chosen.
Pharmacoogical treatment
Carbamazepine:
It is the first line of treatment in the case of glossopharyngeal neuralgia
A rapid response to this drug helps confirm the clinical diagnosis of glossophar
yngeal neuralgia.
Guidelines for the initiation/administration of Carbamazepine:
o
Order baseline complete blood count, blood chemistry, and urinalysis bef
ore initiation of therapy.
o
Start therapy slowly if the pain is not out of control.
o
Begin with a 200-mg bedtime dose for 2 nights.
o
Drug is increased in 200-mg increments in equally divided doses every 2
days, as side effects allow, until pain relief is obtained or a total dose of 12
00 mg daily is reached.
o
Patient is cautioned regarding side effects, including dizziness, sedati
on, confusion, and rash.
o
Carefully monitor laboratory data to avoid life-threatening blood dyscra
sias.
o
Discontinue drug at the first sign of blood count abnormality or rash.
o
After pain relief is obtained, the patient should be left at this dose o
f carbamazepine for at least 6 months before tapering.
o
Patient should be informed that under no circumstances should the dose o
f drug be changed or the prescription refilled or discontinued without consultat
ion with the pain management specialist.
o
Patient should be aware that premature tapering or discontinuation may l
ead to recurrence of pain with subsequent pain control being more difficult.
o
Hospitalize patients for pain emergencies.
Gabapentin:
In the patient in whom carbamazepine does not adequately control the pain of glo
ssopharyngeal neuralgia, gabapentin is the next step
Guidelines for the use of Gabapentin:
o
Order baseline complete blood count, blood chemistry, and urinalysis.
o
Begin treatment with 300-mg bedtime dose for 2 nights.
o
Increase drug in 300-mg increments in equally divided doses every 2 days
, as side effects allow, until pain relief is obtained or a total dose of 300 mg
daily is reached.
o
If patient has experienced partial pain relief, blood level is drawn and
the drug is carefully titrated upward with 100-mg tablets.
o
Rarely is more than 2400 mg needed to control pain.
o
Patient is cautioned regarding side effects, including dizziness, sedati
on, confusion, and rash.
Baclofen:
Baclofen has been reported to be of value in some patients with glossopharyngeal
neuralgia who do not obtain relief from carbamazepine and gabapentin
Guidelines for the use of Baclofen:
o
Order baseline complete blood count, blood chemistry, and urinalysis.
o
Begin treatment with 10 mg at bedtime for 2 nights.
o
Increase drug in 10-mg increments in equally divided doses every 5 days,
as side effects allow, until pain is controlled or a total dose of 80 mg daily
is reached.
o
Patient is cautioned regarding side effects, including dizziness, sedati
on, confusion, and rash.
Other Procedures/Invasive interventions:
Glossopharyngeal Nerve Block
Neurodesrtucive procedures
Microvascular Decompression of the Glossopharyngeal Root
In essence, the treating clinician should be aware of the severity of pain and n
ot dismiss the suffering endured by the patient, and must target an effective an
algesic protocol.
==
Neck Pain
Overview:
Neck pain is one of the most common pains. It can be due to number of disorders
and diseases of any tissues in the neck. Neck holds various vascular, neural and
extensions of visceral structures. The spinal cord passes from foramen magnum t
o thoracic area through a bony tunnel formed by cervical vertebrae. Cervical spi
ne also permits high mobility compared to other parts of spine probable this may
be the risk factor for neck pain many times. Ligaments and muscles protect vita
l tissue structures in neck from injuries. The annual incidence of neck pain is
reported as being as high as 15%. Reliable sources report that cervical spine de
generative disorders are more common that those affecting the lumbar spine and d
evelops at an earlier age.
Causes:
Various mechanical and non-mechanical factors contribute to the neck pain for ex
ample heavy manual duties involving heavy weight, smoking, driving, operating vi
bration equipment and awkward neck postures during sleep and work.
Muscle sprain / strain (i.e. whiplash) is a common cause of neck pain. Such diso
rders are self-limiting and usually improve in days to a few weeks. Parts of the
cervical spine that may be involved include:
Cervical facet joints or zygapophyseal joints allow the neck to flex, extend, an
d rotate. These small joints are susceptible to arthritis and injury.
Cervical intervertebral discs may bulge, herniate, and prone to other degenerati
ve problems. Cervical disc bulges or herniations may cause nerve irritation or i
mpingement resulting in pain and numbness is course of nerve.
Degenerative disc disease is an often an over-use or age-related condition. Unli
ke whiplash which is an immediate one-time injury, degenerative disorders develo
p over time from over-use and abnormal wear and tear, such as repeated heavy lif
ting. Such abnormal wear and tear may cause micro-traumas that can weaken soft t
issues in the neck.
Spondylosis or spinal osteoarthritis is a common cervical degenerative disorder.
Osteophytes are bony overgrowths. An osteophyte may irritate or impinge a spinal
nerve causing inflammation and pain.
Cervical radiculopathy is pain described as electric or shooting pain. Disc hern
iation and osteophyte formation are common causes.
Signs and symptoms:
Pain: dull aching pain in case of minor whiplash injuries, focal axial neck pain
and occipital headaches is usually originates from the cervical intervertebral
discs. In case with nerve root irritation (cervical radiculopathy) patient compl
aint of pins and needles, burning, shooting lancinating pain in a dermatomal pat
tern.
Radiation: pain may radiate up to the occiput (intervertebral disk problems) and
down to shoulder, arm and even fingers (Cervical radiculopathy). Many of the ti
mes pain is unilateral but some time occurs bilaterally.
Limitation to movement is due to pain (whiplash, facet joints, and intervertebra
l discs dysfunctions) sometime movement decreases due to Stiffness (spondylosis)
. Pain symptoms are usually unilateral sometimes occurs bilaterally. Also moveme
nt away from the affected side relieve the symptoms and movement towards the aff
ected side reproduce the symptoms.
Numbness and weakness: in case of cervical radiculopathy neck pain is associated
with numbness in the course of the affected nerve and weakness in the upper ext
remity function especially hand grip.
Red flag symptoms such as fever, unexplained weight loss, previous history of ca
ncer, immunosuppression or intravenous drug use should warn the clinician to loo
k for tumour or infection. Also look for the symptoms of cervical myelopathy, wh
ich are diffuse hand weakness and clumsiness, difficulty with balance, urinary d
. When correctly performed in the right patients the results are excellent. When
performed badly, at best it will not work and at worst the consequences can be
disastrous. After this technique, there is usually a period of increased pain th
at can be sever and may last a few days to few weeks and may require strong anal
gesics, including opioids. It is important that the patient is aware of this. Th
ey also need to be aware that there will be sensory loss in the skin from the ne
ck down towards the trapezius which usually lasts for three to six months.
Nucleoplasty:
It is a percutaneous disc decompression using coblation technology. This involve
s passing a wand to the cervical disc, which evaporates the nucleus pulposus wit
hout producing much heat damage to the surrounding tissues. On healing, the disc
shrinks and takes the pressure away from the nerve root. This is ideal for smal
l disc bulge with corresponding nerve root symptoms not responding to all conser
vative treatments.
Surgery:
In appropriate selected patients surgery may relieve symptoms. Procedures, such
as discectomy, laminectomy, and fusion, including disc replacements have been ad
vocated in managing radiculopathy. Future treatments will be more biological wit
h gene therapy so that disc can regenerate.
==
Costosternal Syndrome
Introduction:
Clinical condition characterized by pain and tenderness at costochondral or chon
drosternal joints of the anterior chest wall without swelling or induration, usu
ally at multiple levels.
Also known as:
Anterior chest wall syndrome
Chest wall pain syndrome
Costochondritis
Parasternal chondrodynia
approximately 28% of undifferentiated noncardiac chest pain patients
more common in women
age greater than 40yrs.
Cause:
arthritis, including osteoarthritis, rheumatoid arthritis, ankylosing spondyliti
s, Reiter's syndrome, and psoriatic arthritis.
Trauma
Overuse or misuse
inflammation
invasion by tumor from primary malignant diseases, including thymoma, and metast
atic disease.
Clinical features:
aggravated by coughing, sneezing, deep inspiration, or any chest-wall movement.
patient attempts to splint the joints by keeping the shoulders stiffly in neutra
l position.
Pain is reproduced with active protraction or retraction of the shoulder, deep i
nspiration, and full elevation of the arm. Shrugging of the shoulder may also re
produce the pain.
Coughing may be difficult, and this may lead to inadequate pulmonary toilet in p
atients who have sustained trauma to the anterior chest wall.
tender
clicking sensation with movement of the joint.
Diagnosis:
Plain radiographs
If trauma = radionuclide bone scanning may be useful to exclude occult fracture
s
complete blood count,
Intercostal Neuralgia
Iintercostal neuralgia is neuropathic
If the subcostal nerve is involved, patients may believe they are suffering from
gallbladder disease.
Causes:
Occurs commonly after thoracotomy. It can also be seen in elderly debilitated pa
tients without a known precipitating event. Other causes include rib trauma, ben
ign periosteal lipoma and pregnancy.
Clinical features:
The pain is constant and burning in nature and may involve any of the intercosta
l nerves as well as the subcostal nerve of the twelfth rib.
The pain usually begins at the posterior axillary line and radiates anteriorly i
nto the distribution of the affected intercostal or subcostal nerves, or both.
Deep inspiration or movement of the chest wall may slightly increase the pain of
intercostal neuralgia, but to a much lesser extent compared with the pain assoc
iated with the musculoskeletal causes of chest wall pain, such as costosternal j
oint pain, Tietze's syndrome, and broken ribs.
Pain is unilateral
Has typical features of neuropathic pain
dysesthesias, paroxysmal pain and allod
ynia
o
Dysesthetic pain is an abnormal sensation described as unpleasant. Patie
nts commonly use the terms such as aching, cramping, pressure and heat to descri
be a dysesthetic pain.
o
Paroxysmal pain is pain that comes in waves and is often described as la
ncinating or electric.
o
Allodynia is abnormal perception of pain after a normally non-painful me
chanical or thermal stimulus. Patients with allodynia respond to light touch wit
h an exaggerated pain response or report a sensation of heat when a cold stimulu
s is applied.
Physical examination generally reveals minimal findings unless the patient has a
history of previous thoracic or subcostal surgery or cutaneous evidence of herp
es zoster involving the thoracic dermatomes.
Unlike patients with musculoskeletal causes of chest wall and subcostal pain, th
ose with intercostal neuralgia do not attempt to splint or protect the affected
area.
Careful sensory examination of the affected dermatomes may reveal decreased sens
ation or allodynia.
When motor involvement of the subcostal nerve is significant, the patient may co
mplain that his or her abdomen bulges outward.
Diagnosis:
Plain radiographs
If trauma radionuclide bone scanning
complete blood count,
prostate-specific antigen level,
erythrocyte sedimentation rate,
antinuclear antibody testing.
Computed tomography of the thoracic contents is indicated if an occult mass is s
uspected.
Differential diagnosis:
Cardiac or gallbladder origin
Trauma
Tietze's syndrome
diabetic polyneuropathies
acute herpes zoster
Treatment:
Initial
non-steroidal anti-inflammatory
Ifdo not control
tricyclic antidepressant /gabepentin should be added.
heat and cold
The use of an elastic rib belt
The patient is placed in the prone position with the patient's arm hanging loose
ly off the side of the cart. Alternatively, this block can be done with the pati
ent in the sitting or lateral position. The rib to be blocked is identified by p
alpating its path at the posterior axillary line. Subsequent daily nerve blocks
are carried out in a similar manner, substituting 40 mg methylprednisolone for t
he initial 80-mg dose. Because of the overlapping innervation of the chest and u
pper abdominal wall, the intercostal nerves above and below the nerve suspected
of subserving the painful condition will have to be blocked.